PURPOSE: We aimed to investigate whether patient self-evaluated symptoms transmitted via Internet can be used between planned visits to provide an early indication of disease relapse in lung cancer. METHODS: Between 2/2013 and 8/2013, 42 patients with lung cancer having access to Internet were prospectively recruited to weekly fill a form of 11 self-assessed symptoms called "sentinel follow-up". Data were sent to the oncologist in real-time between planned visits. An alert email was sent to oncologist when self-scored symptoms matched some predefined criteria. Follow-up visit and imaging were then organized after a phone call for confirming suspect symptoms. Weekly and monthly compliances, easiness with which patients used the web-application and the accuracy of the sentinel follow-up for relapse detection were assessed and compared to a routine visit and imaging follow-up. RESULTS: Median follow-up duration was 18 weeks (8-32). Weekly and monthly average compliances were 79 and 94 %, respectively. Sixty percents of patients declared to be less anxious during the few days before planned visit and imaging with the sentinel follow-up than without. Sensitivity, specificity, positive, and negative predictive values provided by the sentinel (planned imaging) follow-up were 100 %(84 %), 89 %(96 %), 81 %(91 %), and 100 %(93 %), respectively and well correlated with relapse (pχ (2) < 0.001). On average, relapses were detectable 5 weeks earlier with sentinel than planned visit. CONCLUSION: An individualized cancer follow-up that schedule visit and imaging according to the patient status based on weekly self-reported symptoms transmitted via Internet is feasible with high compliance. It may even provide earlier detection of lung cancer relapse and care.
PURPOSE: We aimed to investigate whether patient self-evaluated symptoms transmitted via Internet can be used between planned visits to provide an early indication of disease relapse in lung cancer. METHODS: Between 2/2013 and 8/2013, 42 patients with lung cancer having access to Internet were prospectively recruited to weekly fill a form of 11 self-assessed symptoms called "sentinel follow-up". Data were sent to the oncologist in real-time between planned visits. An alert email was sent to oncologist when self-scored symptoms matched some predefined criteria. Follow-up visit and imaging were then organized after a phone call for confirming suspect symptoms. Weekly and monthly compliances, easiness with which patients used the web-application and the accuracy of the sentinel follow-up for relapse detection were assessed and compared to a routine visit and imaging follow-up. RESULTS: Median follow-up duration was 18 weeks (8-32). Weekly and monthly average compliances were 79 and 94 %, respectively. Sixty percents of patients declared to be less anxious during the few days before planned visit and imaging with the sentinel follow-up than without. Sensitivity, specificity, positive, and negative predictive values provided by the sentinel (planned imaging) follow-up were 100 %(84 %), 89 %(96 %), 81 %(91 %), and 100 %(93 %), respectively and well correlated with relapse (pχ (2) < 0.001). On average, relapses were detectable 5 weeks earlier with sentinel than planned visit. CONCLUSION: An individualized cancer follow-up that schedule visit and imaging according to the patient status based on weekly self-reported symptoms transmitted via Internet is feasible with high compliance. It may even provide earlier detection of lung cancer relapse and care.
Authors: David G Pfister; David H Johnson; Christopher G Azzoli; William Sause; Thomas J Smith; Sherman Baker; Jemi Olak; Diane Stover; John R Strawn; Andrew T Turrisi; Mark R Somerfield Journal: J Clin Oncol Date: 2003-12-22 Impact factor: 44.544
Authors: Fabrice Denis; Louise Viger; Alexandre Charron; Eric Voog; Christophe Letellier Journal: Support Care Cancer Date: 2013-09-01 Impact factor: 3.603
Authors: G L Walsh; M O'Connor; K M Willis; M Milas; R S Wong; J C Nesbitt; J B Putnam; J J Lee; J A Roth Journal: Ann Thorac Surg Date: 1995-12 Impact factor: 4.330
Authors: Filomena Narducci; Roberta Grande; Lucia Mentuccia; Tiziana Trapasso; Isabella Sperduti; Emanuela Magnolfi; Anna Maria Fariello; Donatello Gemma; Teresa Gamucci Journal: Support Care Cancer Date: 2011-06-19 Impact factor: 3.603
Authors: Timothy J Judson; Antonia V Bennett; Lauren J Rogak; Laura Sit; Allison Barz; Mark G Kris; Clifford A Hudis; Howard I Scher; Paul Sabattini; Deborah Schrag; Ethan Basch Journal: J Clin Oncol Date: 2013-06-03 Impact factor: 44.544
Authors: M Catherine Pietanza; Ethan M Basch; Alex Lash; Lawrence H Schwartz; Michelle S Ginsberg; Binsheng Zhao; Marwan Shouery; Mary Shaw; Lauren J Rogak; Manda Wilson; Aaron Gabow; Marcia Latif; Kai-Hsiung Lin; Qinfei Wu; Samantha L Kass; Claire P Miller; Leslie Tyson; Dyana K Sumner; Alison Berkowitz-Hergianto; Camelia S Sima; Mark G Kris Journal: J Clin Oncol Date: 2013-04-29 Impact factor: 44.544
Authors: Ethan Basch; Alexia Iasonos; Allison Barz; Ann Culkin; Mark G Kris; David Artz; Paul Fearn; John Speakman; Rena Farquhar; Howard I Scher; Mary McCabe; Deborah Schrag Journal: J Clin Oncol Date: 2007-12-01 Impact factor: 44.544
Authors: Haley K Perlow; Stephen J Ramey; Vincent Cassidy; Deukwoo Kwon; Benjamin Farnia; Elizabeth Nicolli; Michael A Samuels; Laura Freedman; Nagy Elsayyad; Raphael Yechieli; Stuart E Samuels Journal: Laryngoscope Date: 2018-12-24 Impact factor: 3.325
Authors: Heidi N Beadnall; Kushi E Kuppanda; Annmaree O'Connell; Todd A Hardy; Stephen W Reddel; Michael H Barnett Journal: Ann Clin Transl Neurol Date: 2015-05-01 Impact factor: 4.511
Authors: Kerstin A Kessel; Marco M E Vogel; Friederike Schmidt-Graf; Stephanie E Combs Journal: J Med Internet Res Date: 2016-11-24 Impact factor: 5.428
Authors: Kerstin Anne Kessel; Marco Me Vogel; Carmen Kessel; Henning Bier; Tilo Biedermann; Helmut Friess; Peter Herschbach; Rüdiger von Eisenhart-Rothe; Bernhard Meyer; Marion Kiechle; Ulrich Keller; Christian Peschel; Roland M Schmid; Stephanie E Combs Journal: JMIR Mhealth Uhealth Date: 2017-06-14 Impact factor: 4.773
Authors: Jacqueline L Bender; David Wiljer; Anna M Sawka; Richard Tsang; Nour Alkazaz; James D Brierley Journal: Support Care Cancer Date: 2015-11-03 Impact factor: 3.359